FluoretiQ
Neciah leads the company’s vision to safeguard antibiotic use with rapid bacterial diagnostics. Since co-founding the company in 2017, he has attracted grant and investment funding opportunities and forged long-term strategic partnerships to ensure patients receive the most effective antibiotic first time; Saving Time, Saving Money and most importantly Saving Lives.